Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-007557

Chief Commercial Officer sold 17,000 shares at an average $175.99 ($2,991,765)

  • Chief Commercial Officer acquired 17,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CRUTCHFIELD BRADFORD · Chief Commercial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Exercise or conversion : show line 1 in the form +17,000 $1.16 $19,720 51,608 D
2021-02-01 Sale : show line 2 in the form −746 $173.99 $129,796 50,862 D
2021-02-01 Sale : show line 3 in the form −4,003 $175.25 $701,522 46,859 D
2021-02-01 Sale : show line 4 in the form −8,451 $175.94 $1,486,839 38,408 D
2021-02-01 Sale : show line 5 in the form −2,700 $176.94 $477,751 35,708 D
2021-02-01 Sale : show line 6 in the form −900 $177.86 $160,073 34,808 D
2021-02-01 Sale : show line 7 in the form −200 $178.92 $35,783 34,608 D
Open-market sales · 17,000 sh · avg $175.99 · $2,991,765

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-01 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −17,000 $1.16 2027-02-03 17,000 596,000 D
Loading xslF345X03/doc4.xml…